Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment

Authors: Ivana Burazor, Sarit Aviel-Ronen, Massimo Imazio, Orly Goitein, Marina Perelman, Natalia Shelestovich, Ninoslav Radovanovic, Vladimir Kanjuh, Iris Barshack, Yehuda Adler

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence.

Methods

Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23 years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed.

Results

Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors.

Conclusions

Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition.
Literature
1.
Al Mamgani A, Baartman L, Baaujens M, de Pree I, Incrocci L, Levendag P. Cardiac metastases. Int J Clin Onclol. 2008;13(4):369–72.CrossRef
2.
Radovanovic N. Tumors of the heart. In: Radovanovi N, Jakovljevic Dj KV, editors. editors Quality of life after open heart surgery. Serbian Academy of Sciences and arts. Belgrade, Serbia; 2008. p. 254–7.
3.
Vlachostregios P, Daliani D, Papandreou C. Basic Concepts in metastatic cardiac disease. Cardiol Res. 2012;3(2):47–8.
4.
Borsaru A, Lau K, Solin P. Cardiac metastasis: a cause of recurrent pulmonary emboli. Br J Radiol. 2007;80(950):e50–3.CrossRefPubMed
5.
Tazelaar H. Metastatic tumours. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO classification of Tumours of the lung, pleura, thymus and heart. 4th ed. Lyon, PA: IARC; 2015. p. 342–3.
6.
7.
Stecker T, Rosch J, Weyand M, Agaimy A. Primary and metastatic cardiac tumors:imaging characteristics, surgical treatment and histopathological spectrum: a 10-years –experience at a Geramn heart center. Cardiovasc Pathol. 2012;21(5):436–43.CrossRef
8.
Silvestri F, Bussani R, Pavletic N, Mannone T. Metastases of the heart and pericardium. G Ital Cardiol. 1997;27(12):1252–5.
9.
Hall R, Cooley D, Jr MAH, Frazier O, Neoplastic O’RA. Heart disease. In: Fuster V, Alexander RW, O’Rourke RA, Roberts R, King SB, Prystowsky EN, et al., editors. Hurst’s the heart. 11th ed. New York: McGraw-Hill; 2004. p. 2081–96.
10.
Lee EY, Choi JO, Park HN, Park EJ, Lee GS, Park JY, et al. Malignant melanoma of unknown primary origin presenting as cardiac metastasis. Korean Circ J. 2012;42:278–80.CrossRefPubMedPubMedCentral
11.
Savoia P, Fierro MT, Zaccagna A, Bernengo MG. Metastatic melanoma of the heart. J Surg Oncol. 2000;75(3):203–7.CrossRefPubMed
12.
13.
Kasai T, Kishi K, Kawabata M, Narui K, Momomura S, Yoshimura K. Cardiac metastasis from lung adenocarcinoma causing atrioventricular block and left ventricular outflow tract obstruction. Chest. 2007;131:1569–72.CrossRefPubMed
14.
Taghavi F, Markar S, Williams M, Large S. Intra-cardiac metastasis from testicular non-seminoma germ cell tumor; to resect or not to resect. Interact Cardiovasc Thorac Surg. 2010;11(6):843–5.CrossRefPubMed
15.
Reyner K, Kockeritz U, Strasser R. Metastases to the heart. Ann Oncol. 2004;15(3):375–81.CrossRef
16.
Hanley P, Shub C, Seward J, Wold L. Intracavitary cardiac melanoma diagnosed by endomyocardial left ventricular biopsy. Chest. 1983;84:195–8.PubMed
17.
Ravikumar T, Topulos G, Anderson R, Grage T. Surgical resection for isolated cardiac metastases. Arch Surg. 1983;118:117–20.CrossRefPubMed
18.
Aerts B, Kock M, Kofflard M, Plaisie P. Cardiac metastasis of malignant melanoma: a case report. Neth Heart J. 2014;22(1):39–41.CrossRefPubMed
19.
Kubac G, Doris I, Ondro M, Davey PW. Malignant granular cell myoblastoma with metastatic cardiac involvement: case report and echocardiogram. Am Heart J. 1980;100(2):227–9.CrossRefPubMed
20.
Goldberg A, Blankstein R, Padera R. Tumors metastatic to the heart. Circulation. 2013;128(16):1790–4.CrossRefPubMed
21.
Bogren H, DeMaria A, Mason D. Imaging procedures in the detection of cardiac tumors with emphasis on echocardiography: a review. Cardiovac Intervent Radiol. 1980;3(3):107–25.CrossRef
22.
Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53(6):856–63.CrossRefPubMed
23.
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and Management of Pericardial Diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–64. Epub 2015 Aug 29CrossRefPubMed
24.
Dragoescu EA, Liu L. Pericardial fluid cytology. An analysis of 128 specimens over a 6-year period. Cancer Cytopathol. 2013;121(5):242–51.CrossRefPubMed
25.
Casella M, Carbucicchio C, Dello Russo A, Tundo F, Bartoletti S, Monti L, et al. Radiofrequency catheter ablation of life-threatening ventricular arrhythmias caused by left ventricular metastatic infiltration. Circ Arrhythm Electrophysiol. 2011;4:e7–10.CrossRefPubMed
26.
Kotani E, Kiuchi K, Takayama M, takeno T, tabata M, Aramaki T, et al. Effectiveness of transcoronary chemoembolization for metastatic right ventricular tumor derived from hepatocellular carcinoma. Chest. 2000;117(1):287–9.CrossRefPubMed
27.
Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac Tumors--diagnosis and surgical treatment. Dtsch Arztebl Int. 2014 Mar 21;111(12):205–11.PubMedPubMedCentral
Metadata
Title
Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
Authors
Ivana Burazor
Sarit Aviel-Ronen
Massimo Imazio
Orly Goitein
Marina Perelman
Natalia Shelestovich
Ninoslav Radovanovic
Vladimir Kanjuh
Iris Barshack
Yehuda Adler
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4070-x

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Study protocol

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

Research article

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Research article

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas

Research article

Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma

Debate

Working to improve the management of sarcoma patients across Europe: a policy checklist

Research article

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits